Sargent Investment Group, LLC Lucid Diagnostics Inc. Transaction History
Sargent Investment Group, LLC
- $616 Million
- Q4 2024
A detailed history of Sargent Investment Group, LLC transactions in Lucid Diagnostics Inc. stock. As of the latest transaction made, Sargent Investment Group, LLC holds 541,500 shares of LUCD stock, worth $476,520. This represents 0.07% of its overall portfolio holdings.
Number of Shares
541,500Holding current value
$476,520% of portfolio
0.07%Shares
1 transactions
Others Institutions Holding LUCD
# of Institutions
29Shares Held
3.06MCall Options Held
0Put Options Held
0-
Luminus Management LLC Houston, TX1.15MShares$1.01 Million0.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA561KShares$493,6050.0% of portfolio
-
Geode Capital Management, LLC Boston, MA214KShares$187,9150.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT126KShares$111,1980.01% of portfolio
-
Lido Advisors, LLC Los Angeles, CA100KShares$88,0140.0% of portfolio
About Lucid Diagnostics Inc.
- Ticker LUCD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 38,568,500
- Market Cap $33.9M
- Description
- Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...